Jon Amund Kyte retweeted
Excited to announce our pioneer ICON clinical trial study published in @jitcancer. Thanks to our patients, collaborators, and funders (BMS, Health Region South East, Pink Ribbon/Norwegian Cancer Society). #MATRIX #Oncodistinct #JulesBordet jitc.bmj.com/content/12/1/e0…
Jon Amund Kyte retweeted
On February 9th, Andreas Hagen Røssevold triumphantly completed his Ph.D. defense on "Immunotherapy and immunological biomarkers in breast cancer" at the OUH. For more details on his groundbreaking research, read his recent publications on @NatureMedicine and @jitcancer.
Jon Amund Kyte retweeted
Vi gratulerer Johanna Olweus & The Matchmakers som er en av fem vinnere av Cancer Grand Challenges og får 250 millioner til å løse en av de store utfordringene unnen kreftforskning instagram.com/reel/C5QKl28h4…
Jon Amund Kyte retweeted
Delighted to share that our article "Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation" has been published npj Breast Cancer
nature.com/articles/s41523-0…